SENP8 and amyotrophic lateral sclerosis: In disease-relevant model systems including patient-derived fibroblasts and C. elegans models for ALS, NEDP1 inhibition demonstrated a strong correlation between pathological aggregate clearance and amelioration of ALS-related pathological defects.